Cargando…

Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria

BACKGROUND: Patients with phenylketonuria (PKU) have to follow a lifelong phenylalanine restricted diet. This type of diet markedly reduces the intake of saturated and unsaturated fatty acids especially long chain polyunsaturated fatty acids (LC-PUFA). Long-chain saturated fatty acids are substrates...

Descripción completa

Detalles Bibliográficos
Autores principales: Mütze, Ulrike, Beblo, Skadi, Kortz, Linda, Matthies, Claudia, Koletzko, Berthold, Bruegel, Mathias, Rohde, Carmen, Thiery, Joachim, Kiess, Wieland, Ceglarek, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418234/
https://www.ncbi.nlm.nih.gov/pubmed/22912778
http://dx.doi.org/10.1371/journal.pone.0043021
_version_ 1782240615471251456
author Mütze, Ulrike
Beblo, Skadi
Kortz, Linda
Matthies, Claudia
Koletzko, Berthold
Bruegel, Mathias
Rohde, Carmen
Thiery, Joachim
Kiess, Wieland
Ceglarek, Uta
author_facet Mütze, Ulrike
Beblo, Skadi
Kortz, Linda
Matthies, Claudia
Koletzko, Berthold
Bruegel, Mathias
Rohde, Carmen
Thiery, Joachim
Kiess, Wieland
Ceglarek, Uta
author_sort Mütze, Ulrike
collection PubMed
description BACKGROUND: Patients with phenylketonuria (PKU) have to follow a lifelong phenylalanine restricted diet. This type of diet markedly reduces the intake of saturated and unsaturated fatty acids especially long chain polyunsaturated fatty acids (LC-PUFA). Long-chain saturated fatty acids are substrates of mitochondrial fatty acid oxidation for acetyl-CoA production. LC-PUFA are discussed to affect inflammatory and haemostaseological processes in health and disease. The influence of the long term PKU diet on fatty acid metabolism with a special focus on platelet eicosanoid metabolism has been investigated in the study presented here. METHODOLOGY/PRINCIPAL FINDINGS: 12 children with PKU under good metabolic control and 8 healthy controls were included. Activated fatty acids (acylcarnitines C6–C18) in dried blood and the cholesterol metabolism in serum were analyzed by liquid chromatographic tandem mass spectrometry (LC-MS/MS). Fatty acid composition of plasma glycerophospholipids was determined by gas chromatography. LC-PUFA metabolites were analyzed in supernatants by LC-MS/MS before and after platelet activation and aggregation using a standardized protocol. Patients with PKU had significantly lower free carnitine and lower activated fatty acids in dried blood compared to controls. Phytosterols as marker of cholesterol (re-) absorption were not influenced by the dietary fatty acid restriction. Fatty acid composition in glycerophospholipids was comparable to that of healthy controls. However, patients with PKU showed significantly increased concentrations of y-linolenic acid (C18:3n-6) a precursor of arachidonic acid. In the PKU patients significantly higher platelet counts were observed. After activation with collagen platelet aggregation and thromboxane B(2) and thromboxane B(3) release did not differ from that of healthy controls. CONCLUSION/SIGNIFICANCE: Long-term dietary fatty acid restriction influenced the intermediates of mitochondrial beta-oxidation. No functional influence on unsaturated fatty acid metabolism and platelet aggregation in patients with PKU was detected.
format Online
Article
Text
id pubmed-3418234
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34182342012-08-21 Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria Mütze, Ulrike Beblo, Skadi Kortz, Linda Matthies, Claudia Koletzko, Berthold Bruegel, Mathias Rohde, Carmen Thiery, Joachim Kiess, Wieland Ceglarek, Uta PLoS One Research Article BACKGROUND: Patients with phenylketonuria (PKU) have to follow a lifelong phenylalanine restricted diet. This type of diet markedly reduces the intake of saturated and unsaturated fatty acids especially long chain polyunsaturated fatty acids (LC-PUFA). Long-chain saturated fatty acids are substrates of mitochondrial fatty acid oxidation for acetyl-CoA production. LC-PUFA are discussed to affect inflammatory and haemostaseological processes in health and disease. The influence of the long term PKU diet on fatty acid metabolism with a special focus on platelet eicosanoid metabolism has been investigated in the study presented here. METHODOLOGY/PRINCIPAL FINDINGS: 12 children with PKU under good metabolic control and 8 healthy controls were included. Activated fatty acids (acylcarnitines C6–C18) in dried blood and the cholesterol metabolism in serum were analyzed by liquid chromatographic tandem mass spectrometry (LC-MS/MS). Fatty acid composition of plasma glycerophospholipids was determined by gas chromatography. LC-PUFA metabolites were analyzed in supernatants by LC-MS/MS before and after platelet activation and aggregation using a standardized protocol. Patients with PKU had significantly lower free carnitine and lower activated fatty acids in dried blood compared to controls. Phytosterols as marker of cholesterol (re-) absorption were not influenced by the dietary fatty acid restriction. Fatty acid composition in glycerophospholipids was comparable to that of healthy controls. However, patients with PKU showed significantly increased concentrations of y-linolenic acid (C18:3n-6) a precursor of arachidonic acid. In the PKU patients significantly higher platelet counts were observed. After activation with collagen platelet aggregation and thromboxane B(2) and thromboxane B(3) release did not differ from that of healthy controls. CONCLUSION/SIGNIFICANCE: Long-term dietary fatty acid restriction influenced the intermediates of mitochondrial beta-oxidation. No functional influence on unsaturated fatty acid metabolism and platelet aggregation in patients with PKU was detected. Public Library of Science 2012-08-13 /pmc/articles/PMC3418234/ /pubmed/22912778 http://dx.doi.org/10.1371/journal.pone.0043021 Text en © 2012 Mütze et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Mütze, Ulrike
Beblo, Skadi
Kortz, Linda
Matthies, Claudia
Koletzko, Berthold
Bruegel, Mathias
Rohde, Carmen
Thiery, Joachim
Kiess, Wieland
Ceglarek, Uta
Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria
title Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria
title_full Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria
title_fullStr Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria
title_full_unstemmed Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria
title_short Metabolomics of Dietary Fatty Acid Restriction in Patients with Phenylketonuria
title_sort metabolomics of dietary fatty acid restriction in patients with phenylketonuria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418234/
https://www.ncbi.nlm.nih.gov/pubmed/22912778
http://dx.doi.org/10.1371/journal.pone.0043021
work_keys_str_mv AT mutzeulrike metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT bebloskadi metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT kortzlinda metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT matthiesclaudia metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT koletzkoberthold metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT bruegelmathias metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT rohdecarmen metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT thieryjoachim metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT kiesswieland metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria
AT ceglarekuta metabolomicsofdietaryfattyacidrestrictioninpatientswithphenylketonuria